Work output increased 11% during a 30 minute "all-out" performance test on a bicycle
To date, UBT251 has been approved for clinical trials in China in adult type 2 diabetes, overweight or obesity, metabolic dysfunction-associated fatty liver disease (MAFLD), and chronic kidney disease (CKD), and for clinical trials in the United States in adult type 2 diabetes, overweight or obesity, and CKD
Patients should be instructed to seek immediate medical care if they experience severe, persistent abdominal pain that may radiate to the back
The antioxidant Epitalon restored impaired wound healing in HG-injured ARPE-19 cells by inhibiting hyperglycemia-induced EMT and fibrosis
Appetite and metabolic monitoring
The novel mechanisms and applications of exosomes in dermatology and cutaneous medical aesthetics